Article

AJMC® in the Press, December 9, 2022

Author(s):

Coverage of our peer-reviewed research and news reporting in the health care and mainstream press.

A piece by HealthITAnalytics cited a study pubished in the December 2022 issue of The American Journal of Managed Care® (AJMC®). The study, “On the Impact of Predictive Analytics–Driven Disease Management Interventions,” showed that predictive analytics–driven disease management outperforms standard of care among patients with chronic heart failure.


An article by Wired referenced a study published in a 2016 supplement to AJMC®, titled “Economic Costs of Hemophilia and the Impact of Prophylactic Treatment on Patient Management.” The study indicated that intravenous infusions for the management of hemophilia cost patients an average of $127,194 per year.

Related Videos
James Chalmers, MD
Vincent Picozzi, MD, medical oncologist and director of the pancreaticobiliary program, Virginia Mason
Manmeet Ahluwalia, MD, MBA, FASCO, chief of medical oncology, chief scientific officer, and deputy director of the Miami Cancer Institute of Baptist Health South Florida
1 expert is featured in this series.
Ali Khawar
 Priscilla Tsondai, MD, MPH, International AIDS Society/CIPHER
Eileen Peng, PharmD, sitting for a video interview
ASCO Preview 2025
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo